Published 10 hours ago • loading... • Updated 5 hours ago

Rasonque: FDA Approves Pancreatic Cancer Pill

The Food and Drug Administration approved a once-a-day pill for advanced pancreatic cancer more than six months ahead of target.

9 Articles

Zeit Online

Lean Left

Drug Against Cancer: »A Real Breakthrough«

In the USA, a new remedy for pancreatic cancer has been approved: Daraxonrasib. How it works, when it comes – and what this means for other types of tumours

6 hours ago·Germany

Read Full Article

Cumhuriyet

Lean Left

Historic Breakthrough in Pancreatic Cancer Treatment: Newly Approved Drug Doubles Life Expectancy.

The FDA has officially approved Rasonque (daraxonrasib), a groundbreaking drug for treating pancreatic cancer, one of the deadliest types of cancer. Clinical trials have documented that the drug doubles the survival rate of patients with advanced-stage cancer.

8 hours ago·Istanbul, Türkiye

Read Full Article

Sapo

Lean Right

Pancreatic Cancer: Medicine Approved in the USA Can Reach Europe in a Few Months

The Food and Drug Administration (FDA) has given green light to daraxonrasib, a drug that promises to almost double the survival of patients with advanced pancreatic cancer. In Europe, the equivalent agency has already accelerated the...

8 hours ago·Lisboa, Portugal

Read Full Article

Sioux City Journal

Lean Left

FDA OKs Ben Sasse's 'miracle' pancreatic cancer drug

Daraxonrasib, the "miracle drug" former Nebraska U.S. Sen. Ben Sasse is using to manage his terminal pancreatic cancer diagnosis, was approved by the FDA on Wednesday.

10 hours ago

Read Full Article